Fundz

Who to call at Telomir Pharmaceuticals, and when

Fundz watches for the moments Telomir Pharmaceuticals starts buying, and tells you who to reach.

  • An alert the day Telomir Pharmaceuticals raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Telomir Pharmaceuticals, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Telomir Pharmaceuticals. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Telomir Pharmaceuticals Engages Linical for Clinical Trial Support

Nov 18, 2026

Contract Type

clinical_trial_agreement

MiamiBiotechnologyPharmaceuticalBiopharma

Description

Telomir Pharmaceuticals, Inc. has announced the selection of Linical, a global contract research organization, to assist in its Phase 1/2 clinical trial of Telomir-Zn for advanced triple-negative breast cancer. A Master Services Agreement and clinical trial Work Order have been executed to advance the study toward clinical initiation in the first quarter of 2027. Linical brings over two decades of oncology expertise to support this critical development phase.

Quick answer

Telomir Pharmaceuticals Engages Linical for Clinical Trial Support (November 18, 2026). Telomir Pharmaceuticals is based in Miami, Florida, United States.

What agreement did Telomir Pharmaceuticals announce on November 18, 2026?
Telomir Pharmaceuticals, Inc. has announced the selection of Linical, a global contract research organization, to assist in its Phase 1/2 clinical trial of Telomir-Zn for advanced triple-negative breast cancer. A Master Services Agreement and clinical trial Work Order have been executed to advance the study toward clinical initiation in the first quarter of 2027.
What does Telomir Pharmaceuticals do?
Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of Telomir-1, the first novel small molecule to lengthen the DNA’s protective telomere caps...
Where is Telomir Pharmaceuticals based?
Telomir Pharmaceuticals is based in Miami, Florida, United States.
Which similar companies announced agreements around the same time?
AstraZeneca Pharma India (November 17, 2026), Pfizer (November 14, 2026), Sino Biopharmaceutical (November 13, 2026) and Edesa Biotech (November 9, 2026) also announced agreements within 45 days of Telomir Pharmaceuticals.

Source: Fundz verified event record.

Other recent agreements in Pharmaceutical and Biopharma

Contracts and agreements at companies in the same sectors within 45 days, from Fundz verified event records.

Company Information

Company

Telomir Pharmaceuticals

Location

900 WEST PLATT STREET, SUITE 200

Miami, Florida, United States

About

Telomir Pharmaceuticals, Inc. is a pre-clinical-stage pharmaceutical company focused on the development and commercialization of Telomir-1, the first novel small molecule to lengthen the DNA’s protective telomere caps in order to affect age reversal.

Related People

Erez
Senior decision-maker at this company
••••••••@••••••••

See Erez's verified email →

Create an account to reveal verified emails
Predictive Intelligence
Strategic

ML-powered predictions for Telomir Pharmaceuticals's next move

Learn about Strategic plan

Telomir Pharmaceuticals signed a new agreement. Fundz surfaces partnerships and contracts as they are announced.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.